Literature DB >> 1849432

Coxsackie B virus and postviral fatigue syndrome.

P Muir, F Nicholson, J E Banatvala, P J Bingley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849432      PMCID: PMC1675464          DOI: 10.1136/bmj.302.6777.658-b

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

1.  Coxsackie-B-virus-specific IgM responses in patients with cardiac and other diseases.

Authors:  M M El-Hagrassy; J E Banatvala; D J Coltart
Journal:  Lancet       Date:  1980-11-29       Impact factor: 79.321

2.  Chronic enterovirus infection in patients with postviral fatigue syndrome.

Authors:  G E Yousef; E J Bell; G F Mann; V Murugesan; D G Smith; R A McCartney; J F Mowbray
Journal:  Lancet       Date:  1988-01-23       Impact factor: 79.321

3.  Chronic relapsing pericarditis and dilated cardiomyopathy: serological evidence of persistent enterovirus infection.

Authors:  P Muir; F Nicholson; A J Tilzey; M Signy; T A English; J E Banatvala
Journal:  Lancet       Date:  1989-04-15       Impact factor: 79.321

4.  Antibody to Coxsackie B virus in diagnosing postviral fatigue syndrome.

Authors:  N A Miller; H A Carmichael; B D Calder; P O Behan; E J Bell; R A McCartney; F C Hall
Journal:  BMJ       Date:  1991-01-19

5.  Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus.

Authors:  M L King; A Shaikh; D Bidwell; A Voller; J E Banatvala
Journal:  Lancet       Date:  1983-06-25       Impact factor: 79.321

6.  Postviral fatigue syndrome: persistence of enterovirus RNA in muscle and elevated creatine kinase.

Authors:  L C Archard; N E Bowles; P O Behan; E J Bell; D Doyle
Journal:  J R Soc Med       Date:  1988-06       Impact factor: 5.344

  6 in total
  1 in total

1.  Serological and molecular evidence of enterovirus infection in patients with end-stage dilated cardiomyopathy.

Authors:  P Muir; F Nicholson; S J Illavia; T S McNeil; J F Ajetunmobi; H Dunn; W G Starkey; K N Reetoo; N R Cary; J Parameshwar; J E Banatvala
Journal:  Heart       Date:  1996-09       Impact factor: 5.994

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.